-Live Mint Tariffs reach at least Rs.4 per unit in many states, finds analysis, amid efforts to bail out state discoms Indian domestic consumers in 16 states are paying at least `4 per unit for power and in some cases even more, according to an analysis, thus giving the lie to the long-held axiom that raising tariffs is nearly impossible in India given the political compulsions. The finding also shows conclusively that...
More »SEARCH RESULT
Total Matching Records found : 9940
Indian Express-ICIJ probe: Vijay Mallya, Ravikant Ruia in tax havens -Ritu Sarin
-The Indian Express The 612 Indians on the list of those who have invested in tax havens such as the BRItish Virgin Islands include two MPs, a former royal and top industrialists. RITU SARIN puts together details of 20 among them SONU LALCHAND MIRCHANDANI Mirchandani is the founder of popular consumer electronics firm Onida. Mirchandani and his wife, Soni, opened a BVI company called Strong Wing Overseas Ltd in 2006 with an authorised...
More »Novartis patent ruling a victory in battle for affordable medicines-Sarah Boseley
-The Guardian Had Novartis won, it would have set a precedent for patenting of other medicines in India, delaying their reaching the poor The battle for affordable, life-saving medicines for poor countries was once waged on first-world city streets with banners and placards. But for some years now it has been a long-hard legal slog in offices and courtrooms. A decade or so ago, it was mostly about access to Aids drugs. Firms...
More »President gives his assent to anti-rape bill
-The Times of India President Pranab Mukherjee has given his assent to the tougher anti-rape bill, BRInging into force the new legislation which provides for stringent punishment for rapists and repeat offenders and makes provisions of strict punishment for offences like stalking, voyeurism, disrobing and acid attacks. Presidential assent to the Criminal Law (Amendment) Bill, 2013, came on Tuesday - just two days before the February 3 Ordinance on the issue was...
More »Domestic firms rejoicing on Glivec verdict-Sushmi Dey
-The Business Standard Now, local firms can sell their low-priced generic version of the drug in India and export it to developing markets, where it is not patented Domestic drug firms such as Cipla, Natco, Ranbaxy and Hetero are a happier lot following the Supreme Court verdict on Monday, dismissing Novartis AG's patent plea for anti-cancer drug imatinib mesylate or Glivec, as sold by the Swiss drug maker. This is because the judgement...
More »
